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tions including IA. Th2 cytokines, i.e. interleukin-4 and -10, have down-
regulatory effects on antifungal phagocytic activity against A. fumigatus.
Neutralization of these cytokines and their immunosuppressive function has
beneficial effects on murine models of IA. The in virro and in vivo
demonstrations of improved outcome of IA by the regulation of these
cytokines offer novel approaches in the management of this serious infection
in immunocompromised patients. Further evaluation of safety and efficacy
of these immunotherapeutic modalities is a new and promising area for
research.
518 - Resistant pneumococci. what we have learnt •..
[fuS3Ol What Is pneumococ:cal resistance? The role of
pharmaco-dynamics in determination of breakpoints
Niels Frimodt-Moller
Dept. o.fClinical Microbiology, Statens Serum Institut, Copenhagen, Denmark.
Penicillin resistance in pneumococci is caused by mutations in the genes
coding for the penicillin-binding proteins (PBP) leading to reduced affinity
for binding of the antibiotics to the PBP's. Additionally changes may take
place in other enzyme systems not related to the PBP's. Increasing number of
mutations in PBP's, or changes due to transformation, leads to increasing
MIC's of beta-lactam antibiotics, while the activities of all other antibiotics
are unaffected. The killing effect of penicillin at similar multiples of the
MIC's is usually the same in susceptible (PSP) and resistant (PRP)strains. If
PBP2x is altered. tolerance towards penicillin may develop. The higher
MIC's have the consequences. that increasing sizes of doses of beta-Iactam
antibiotics are necessary. A clear-cut breakpoint is difficult to define with the
stepwise increase in MIC's. The limit for effect in vivo will be when the
necessary dose to achieve active concentrations at the site ofinfection exceeds
the tolerance of the host. Thus, treating meningitis is problematic due to the
difficulty of beta-lactams to penetrate the blood-brain barrier. Optimal use
of pharmacodynamic principles can, however, reduce the size of the dose
necessary for effect against PRP. It is now clear from various experimental
animal models, that the pharmacokinetic parameters governing the effect in
vivo for penicillins against PSP, i.e. the time> MIC, is the same for PRP's.
Those beta-lactams that have the highest activity against PRP's and that can
achieve high and sustained non-proteinbound concentrations at the site of
infections will therefore have decisive roles in treatment of PRP's. Also,
certain drug combinations can be of benefit against srrains with high MIGs.
ITuS31I Antibiotic treatment Does it make a dierence? The
search for new end points in dinical trials
C. Carbon
Hopital Bichat, Paris, France
Two questions regarding infections in which Streptococcus pneumoniae may
be involved are (i) is antibiotic (AB) treatment always necessary in common
respiratory rract infections (RTis)? (ii) what is the incidence of resistance to
AB on outcome and therapeutic strategies? S. pneumoniM is involved in
different R Tis and may induce severe complications. It is suspected in the
presence of evident clinical symptoms with high fever. Reduced suscept-
ibility to penicillin in R Tis is overcome by increasing amoxicillin doses.
Resistance to macrolides or TMP/SMZ is accompanied by clinical failures.
Clinical trials should only include patients at high risk ofbeing infected by a
pneumococcus and actually needing AB, with discussion of the diagnostic
procedures to get the organism. In phase 2 trials those investigations are
mandatory to establish the intrinsic activity ofthe new drug. In phase 3 trials,
the need for investigations should be based on the current practices for the
given infection. Strong evaluation criteria should be retained to perform an
objective evaluation of the potentialities of the drug. This is easier if only
severe infections are considered. Careful analysis offailures should be made,
along with serum drug levels. Susceptibiliry ofpersisting organisms must be
compared to that of the initial strain. This helps define in vivo breakpoints.
As it is difficult to achieve these goals in clinical trials, in virro and animal
studies on the potential of the new drug to select high level resistant variants
and defmc the limit of the recommended regimens on efficacy are needed.
519 - Intraabdominal infections
ITuS34! Open management of diuse peritonitis
T.Hau
Nordwest-Krankenhaus Sande, Germany
Even though open management of peritonitis is done frequently the
recommendation for its use is based on case series or non-randomized
historic cohort studies. Prospective studies do not show any advantage
over closed techniques. On the basis ofa prospective multicenter study in 334
patients we performed a case controlled study comparing planned re-
laparotomy (PL) to relaparotomy on demand. The matching was based
on the age of the patient, the number of coexisting diseases, the acute
physiology, Score" and the secure source control all ofwhich were found to
be significant prognostic factors. There was no difference in mortality, MOF
and infectious complications due to suture leaIts, recurrent intraabdominal
infections and septicemia were more common after Pi. Some variables in
the PL group, however, indicated that there might be certain subgroups of
patients which may benefit from this procedure and that technical details of
the procedure are important.
In summary, indications for PL should be made with caution. The most
likely patients to benefit from the procedure will be those in whom a proper
peritoneal toilet cannot be performed at the first operation and those who are
in danger of developing an abdominal compartment syndrom.
520 - Management of immunocompromised hosts
with ...
ITuS38I Imaging techniques for early detection and dlerential
diagnosis of pulmonary infiltrates
C. P. Heussel l , H. -U. Kauczor l , A. J. Ullmann2
tDepartment of Radiology; 2111. Medical Department ofMedicine,johlllUres
Gutenberg-University Mainz, Germany
The two major tasks of radiographic imaging in patients with suspected
pneumonia are (1) eady detection including localisation of pulmonary
infiltrates and (2) characterisation of infiltrates for distingnishing between
non-infectious and infectious aetiologies.
Chest radiography (CR) is useful in immunocompetent patients for
detection and follow-up of bacterial pneumonia. However, in immuno-
compromised hosts, during the early phase of infection, CR may fail in
about 50% of the cases to detect an atypical pneumonia. Therefore. more
sensitive methods arc frequently applied. High-resolution computed tomo-
graphy (HRCn, which is the most sensitive technique of computed
tomography to identify infiltrates early on, can safely distinguish between
acute inflammation and non-inflammatory conditions such as scar or
atelectasis. Therefore, CT became the gold standard in chest imaging,
especially in immunocomprornised hosts. CT-scanners are widely available.
The technical requirements and the costs of HRCT and CT are low in
comparison to antibiotics. The radiation dose is about 8-10 fold higher than
in CR (spiral-CT: ~50x). Further techniques are discussed. Pattern recog-
nition in HRCT assists in determining the differential diagnoses. Bacterial.
fungal and viral pneumonia as well as pulmonary congestion, Iymphangio-
sis, graft-versus host disease. graft-rejection and radiation toxicity appear
frequently with specific findings on HRCT.1n comparison to bronchoscopy
and surgery, HRCT is a non-invasive method and offers the clinician
immediately available information for diagnosing a possible underlying
disease. However, this information can be helpful in establishing a diagnosis
but is not always verifiable. Experience, local epidemeology and clinical
information are necessary for the characterisation ofinfiltrates in immuno-
compromised hosts.
ITuS421 Options and limitations of a surgical approach In
patients with invasive pulmonary aspergillosis
M. Tamm
Pneumology, University Hospital Basel, Switzerland; Institute of Re.<piratory
Medicine, University ifSydney, Au.<tralia
Invasive pulmonary aspergillosis (IPA) is a frequent complication in neu-
tropenic patients and associated with a very high mortality. Diagnosis oflPA
is usu:111y based on antibiotic resistant fever combined with localised
infiltrates on CT scan developing in neutropenic patients. Broncboalveolar
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lavage (BAL) has a sensitivity of 43% to detect IPA (12 published studies
including 195 patients with histologically proven IPA). Current treatment of
IPA consists mainly of amphothericin B. Lung resection (LR) for IPA is
rarely considered because of fea .... of peri-operative bleeding and infection.
However. the current literature on LR for IPA (> 100 patients) shows an
acccptable complication ratc: blccding 7°,{,, air leak 4%, infection 3%,
surgery related mortality 1%, 3O-day mortality 9% and fungal relapse
10%. Analysis of 27 paticnts undergoing LR for IPA at our institution
rcvcaled: feasibility of LR irrespective of neutrophil- and platelet counts;
median duration ofoperation 120 min; median blood loss 300 ml; immediate
extubation in 96%; median ICU-stay I day; median duration of chest tube
drainage 2 days; secondary stemcell transplantation possible. Medium term
survival (12 months) was superior in patients undergoing LR compared to
patients with medical treatment alone.
Conclusion: lung resection should be considered in selected neutropenic
patients with invasive pulmonary aspergillosis.
521 - Are all chronic diseases infections?
ITuS46 I Granulomatous diseases: Crohn's disease and
sarcoidosis
F. EI-Zaatari
Baylor College ofMedicine, HOIlSlon, Texas, Ullited States
Background: Crohn's disease (CD) and sarcoidosis (SA) are idiopathic
granulomatous diseases that share many features with mycobacterial infec-
tions. Reports on the association with cell wall deficient (CWO) forms of
Mycobacterium avium subsp. paratuberculosis (Map) are controversial.
Objectives: To confirm/refute the hypothesis of Map involvement in CD
and SA.
Methods and: Results: Our group and others used tissue and serum samples
from CD, SA and control patients to analyze by: 1) advanced cultural
techniques, 2) mycobacteria-specific polymerase chain reaction (PCR)
assays, 3) immunoblotting against recombinant clones expressing Map-
specific 35K (p35) and mycobacteria-specific 36K (p36)-antigens, 4) a
novel in situ hybridization (ISH) technique, bascd on the IS900 (a Map-
specific) probe, that was developed specifically for the detection of CWO
forms of Map, and 5) the recent use of macrolides and anti-mycobacterial
drags therapies.
Results: 1 and 2) CWO mycobacterial cells, specifically Map, were isolated
and/or identified from tissue specimens ofCD and SA and from breast milk
ofpatients with CD; 3) the majority ofCD patients sera (75% of53) reacted
with both p35 and p36 molecules versus only 2% of 58 controls. All 7 SA
patients reacted with p36; 4) CWO Map can be seen deep in fibroblasts, and
in acute and chronic inflammatory cells of active CD intestinal tissues with
granulomas; and 5) long term remission (possibly cure) in an increasing
number of CD patients.
Condusion: All the above evidence would suggest a causal role for myco-
bacteria in both diseases and treatment studies with anti-mycobacterial drags
including macrolides are warranted.
523 - Bacterial ecology and disease - are ...
IWeSSI Probiotics and streptococcal tonsillitis
K. Roos
ENT-dep., Lundby Hospital, Goteborg, Sweden
The significance of the normal fiora for the protection against infection in an
ecologic nisch has lately attracted an increased interest.
In the upper respiratory tract, alpha-streptococci have been in the focus of
interest in this regard. A lower number of alpha-streptococci have been
found in patients with recurrent streptococcal pharyngotonsillitis compared
to healthy controls, but also in otitis-prone children compared to non-otitis
prone and in children with secretory otitis media compared to healthy
children. Certain alpha-streptococci have been shown to have growth
inhibitory activity against common pathogenes in the upper respiratory
tract in vitro. We have shown that patients recolonized with alpha-
streptococci with interfering activity against beta-streptococci group A,
get less recurrences of streptococcal tonsillitis than placebo treated patients.
We have also isolated alpha-streptococcal strains with growth inhibitory
activity against pathogenes of acute otitis media. A significandy higher
number of otitis-prone children recolonized with these strains were healthy
during a randomized controlled study compared to placebo treated.
Conclusions: The results of ecological recolonization studies, both in
patients with streptococcal pharyngotonsillitis and in children with recur-
rent acute otitis media, indicate an important principle and stress the
importance of a normal balance between microorganisms in the upper
respiratory tract. This fact can be used in the protection against renewed
infections by recolonization with selected alpha-streptococcal strains in
paticnts with a disturbed normal fiora.
IWeS71 Probiotics in He/icobacter pylori infections
M. R. Gismondo, H. Mombelli
L. Sacco Teachitlg Hospital, University ofMilatl, ftaly
Interference of normal fiora with pathogenic micro-organisms growth and
vimlence has a long history of empirical observations and. more recently
scientific evidence. Probiotics, particnlarly lactic acid bacteria (Lactobacillus
and Bifidobacterium spp), are known to inhibit the growth of a wide range
of intestinal pathogcns in man and animals. Hdicobacter pylori is a peculiar
gastrointestinal pathogen, able to colonise stomach and cause.' peptic ulcer
and gastritis in man. In vitro studies demonstrated a strain-dependent and
concentration-dependent inhibitory activity ofLactobacilli against H. pylori.
Animal studies using gnotobiotic murine model proved both prevention of
H. pylori infection by Lactobacillus salivarius administration and suppression
of H. pylori by Lactobacillus salivarius administration after infection. The
suppression is supposed to be lactic acid mediated, and these results were also
reproduced with L. acidophilus and confirmed in human trials by oral
administration of sumatant, though H. pylori suppression was temporary.
Since the treatment of H. pylori infection is limited by deleterious side
effects, acquisition ofresistance, and sometimes lack oferadication, the use of
probiotics in prevention or treatment of this disease seems a very attractive
alternativc.
IWeSSI Treatment of diarrhoea with probiotics
S. L. Gorbach
Tujis University School of Medicine, Boston, MA, United States
Lactobacillus GG (LGG), a strain ofL. casei sps rhamnosus, has been studied
extensively with over 100 publications involving adults and children. In 15
placebo-controlled studies of acute diarrhea in children, LGG has been
shown to shorten the duration and reduce the severity ofthe acute episode. In
addition, duration of rotavirus shedding in the stools was reduced. These
studies were reported from various countries, including Finland, Italy,
Estonia, Russia, Thailand, Pakistan, and Peru. Similar findings were
reported recently in a study done in 287 children with acute diarrhea
enrolled in 13 pediatric centers within 10 European countries under the
auspices ofESPGHAN. LGG versus placebo was incorporated in ORS (oral
rehydration solution). The LGG group had significant reductions in dura-
tion of diarrhea and length of hospital stay. Fewer cases of protracted
diarrhea (> 6 days) were also seen in the LGG group. In another trial of
children given antibiotics for various respiratory infections, LGG treatment
was associatcd with less diarrhea side effects than placebo (17% with LGG vs
48% with placebo). The incidence of traveler's diarrhea was cut by 47% by
taking LGG as prophylaxis in a study ofAmcricans traveling to developing
countries. Other studies have shown benefit with LGG in treating cases of
antibiotic-associatcd diarrhea and relapsing Clostridium difficile colitis. LGG
is currendy ingested by millions of consumers each day in 25 countries as
dairy products or medicaments. Its excellent safety record has been docu-
mented by ongoing surveillance studies.
524 - New methods in tracking epidemics
IWeS10 I Surveillance systems responding quickly to
epidemics
O. L. Heymann
World Health Oganizatiotl, Geneva, Switzerland
With continuing globalization in travel and trade, global epidemic surveil-
lance is essential to ensure international public health security, The key
components of global epidemic surveillance are; epidemic intelligence;
epidemic preparedness; co-ordination of epidemic response. Epidemic
intelligence (accurate and timely information) about important disease
outbreaks should be delivered systematically and rapidly to key professionals
